Salva, Kim Bailey F.

HRN: 26-93-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2025
CEFTRIAXONE 1G (VIAL)
04/08/2025
04/15/2025
IV
500mg
OD
PCAP
Waiting Final Action 
04/08/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/08/2025
04/15/2025
IV
45mg
Q6h
Acute Bacterial Infection
Waiting Final Action 
04/13/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/13/2025
04/20/2025
IV
275mg
Q6h
PCAP C
Waiting Final Action 
04/15/2025
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
04/15/2025
04/22/2025
ORAL
2 Ml
Every 12 Hours
PCAP-C
Waiting Final Action 
04/15/2025
MUPIROCIN 2%, 15G (TUBE)
04/15/2025
04/22/2025
TOPICAL
-
Every 12 Hours
Skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: